Cargando…

Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract

BACKGROUND: Fermented wheat germ extract (FWGE) sold under the trade name Avemar exhibits anticancer activity in vitro and in vivo. Its mechanisms of action are divided into antiproliferative and antimetabolic effects. Its influcence on cancer cell metabolism needs further investigation. One objecti...

Descripción completa

Detalles Bibliográficos
Autores principales: Otto, Christoph, Hahlbrock, Theresa, Eich, Kilian, Karaaslan, Ferdi, Jürgens, Constantin, Germer, Christoph-Thomas, Wiegering, Armin, Kämmerer, Ulrike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888675/
https://www.ncbi.nlm.nih.gov/pubmed/27245162
http://dx.doi.org/10.1186/s12906-016-1138-5
_version_ 1782434887358218240
author Otto, Christoph
Hahlbrock, Theresa
Eich, Kilian
Karaaslan, Ferdi
Jürgens, Constantin
Germer, Christoph-Thomas
Wiegering, Armin
Kämmerer, Ulrike
author_facet Otto, Christoph
Hahlbrock, Theresa
Eich, Kilian
Karaaslan, Ferdi
Jürgens, Constantin
Germer, Christoph-Thomas
Wiegering, Armin
Kämmerer, Ulrike
author_sort Otto, Christoph
collection PubMed
description BACKGROUND: Fermented wheat germ extract (FWGE) sold under the trade name Avemar exhibits anticancer activity in vitro and in vivo. Its mechanisms of action are divided into antiproliferative and antimetabolic effects. Its influcence on cancer cell metabolism needs further investigation. One objective of this study, therefore, was to further elucidate the antimetabolic action of FWGE. The anticancer compound 2,6-dimethoxy-1,4-benzoquinone (DMBQ) is the major bioactive compound in FWGE and is probably responsible for its anticancer activity. The second objective of this study was to compare the antiproliferative properties in vitro of FWGE and the DMBQ compound. METHODS: The IC(50) values of FWGE were determined for nine human cancer cell lines after 24 h of culture. The DMBQ compound was used at a concentration of 24 μmol/l, which is equal to the molar concentration of DMBQ in FWGE. Cell viability, cell cycle, cellular redox state, glucose consumption, lactic acid production, cellular ATP levels, and the NADH/NAD(+) ratio were measured. RESULTS: The mean IC(50) value of FWGE for the nine human cancer cell lines tested was 10 mg/ml. Both FWGE (10 mg/ml) and the DMBQ compound (24 μmol/l) induced massive cell damage within 24 h after starting treatment, with changes in the cellular redox state secondary to formation of intracellular reactive oxygen species. Unlike the DMBQ compound, which was only cytotoxic, FWGE exhibited cytostatic and growth delay effects in addition to cytotoxicity. Both cytostatic and growth delay effects were linked to impaired glucose utilization which influenced the cell cycle, cellular ATP levels, and the NADH/NAD(+) ratio. The growth delay effect in response to FWGE treatment led to induction of autophagy. CONCLUSIONS: FWGE and the DMBQ compound both induced oxidative stress-promoted cytotoxicity. In addition, FWGE exhibited cytostatic and growth delay effects associated with impaired glucose utilization which led to autophagy, a possible previously unknown mechanism behind the influence of FWGE on cancer cell metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-016-1138-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4888675
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-48886752016-06-02 Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract Otto, Christoph Hahlbrock, Theresa Eich, Kilian Karaaslan, Ferdi Jürgens, Constantin Germer, Christoph-Thomas Wiegering, Armin Kämmerer, Ulrike BMC Complement Altern Med Research Article BACKGROUND: Fermented wheat germ extract (FWGE) sold under the trade name Avemar exhibits anticancer activity in vitro and in vivo. Its mechanisms of action are divided into antiproliferative and antimetabolic effects. Its influcence on cancer cell metabolism needs further investigation. One objective of this study, therefore, was to further elucidate the antimetabolic action of FWGE. The anticancer compound 2,6-dimethoxy-1,4-benzoquinone (DMBQ) is the major bioactive compound in FWGE and is probably responsible for its anticancer activity. The second objective of this study was to compare the antiproliferative properties in vitro of FWGE and the DMBQ compound. METHODS: The IC(50) values of FWGE were determined for nine human cancer cell lines after 24 h of culture. The DMBQ compound was used at a concentration of 24 μmol/l, which is equal to the molar concentration of DMBQ in FWGE. Cell viability, cell cycle, cellular redox state, glucose consumption, lactic acid production, cellular ATP levels, and the NADH/NAD(+) ratio were measured. RESULTS: The mean IC(50) value of FWGE for the nine human cancer cell lines tested was 10 mg/ml. Both FWGE (10 mg/ml) and the DMBQ compound (24 μmol/l) induced massive cell damage within 24 h after starting treatment, with changes in the cellular redox state secondary to formation of intracellular reactive oxygen species. Unlike the DMBQ compound, which was only cytotoxic, FWGE exhibited cytostatic and growth delay effects in addition to cytotoxicity. Both cytostatic and growth delay effects were linked to impaired glucose utilization which influenced the cell cycle, cellular ATP levels, and the NADH/NAD(+) ratio. The growth delay effect in response to FWGE treatment led to induction of autophagy. CONCLUSIONS: FWGE and the DMBQ compound both induced oxidative stress-promoted cytotoxicity. In addition, FWGE exhibited cytostatic and growth delay effects associated with impaired glucose utilization which led to autophagy, a possible previously unknown mechanism behind the influence of FWGE on cancer cell metabolism. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12906-016-1138-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-06-01 /pmc/articles/PMC4888675/ /pubmed/27245162 http://dx.doi.org/10.1186/s12906-016-1138-5 Text en © The Author(s). 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Otto, Christoph
Hahlbrock, Theresa
Eich, Kilian
Karaaslan, Ferdi
Jürgens, Constantin
Germer, Christoph-Thomas
Wiegering, Armin
Kämmerer, Ulrike
Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
title Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
title_full Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
title_fullStr Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
title_full_unstemmed Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
title_short Antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
title_sort antiproliferative and antimetabolic effects behind the anticancer property of fermented wheat germ extract
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888675/
https://www.ncbi.nlm.nih.gov/pubmed/27245162
http://dx.doi.org/10.1186/s12906-016-1138-5
work_keys_str_mv AT ottochristoph antiproliferativeandantimetaboliceffectsbehindtheanticancerpropertyoffermentedwheatgermextract
AT hahlbrocktheresa antiproliferativeandantimetaboliceffectsbehindtheanticancerpropertyoffermentedwheatgermextract
AT eichkilian antiproliferativeandantimetaboliceffectsbehindtheanticancerpropertyoffermentedwheatgermextract
AT karaaslanferdi antiproliferativeandantimetaboliceffectsbehindtheanticancerpropertyoffermentedwheatgermextract
AT jurgensconstantin antiproliferativeandantimetaboliceffectsbehindtheanticancerpropertyoffermentedwheatgermextract
AT germerchristophthomas antiproliferativeandantimetaboliceffectsbehindtheanticancerpropertyoffermentedwheatgermextract
AT wiegeringarmin antiproliferativeandantimetaboliceffectsbehindtheanticancerpropertyoffermentedwheatgermextract
AT kammererulrike antiproliferativeandantimetaboliceffectsbehindtheanticancerpropertyoffermentedwheatgermextract